November 08, 2018
The makers of a generic blood-pressure drug that was recalled due to contamination by a carcinogen "willfully ignored warning signs" about poor safety procedures in a laboratory in India and should have known their drugs were tainted years before testing revealed it this summer, according to a putative consumer class action filed Wednesday in Boston federal court.